Research

Hold Pfizer India Ltd - Kotak Securities PCG

Posted On : 2006-10-03 04:49:41( TIMEZONE : IST )

Kotak Securities has given a Hold rating on Pfizer India Ltd. The current market price of Pfizer India Ltd is Rs.900.

Source : Kotak Securities

Keywords

Stake Sale

CRISIL Ratings: Revised deposit norms unlikely to be onerous for HFCs
CRISIL Ratings: 6 gigawatt renewable energy storage to be added by fiscal 2028
CRISIL Ratings: Thermal share in power generation to dip over 500 bps next fiscal
Indian bond market issuances exceeded $105 billion, $25 billion new equity issued in FY24 - Shri Pramod Rao, ED, SEBI
One third of Nifty 100 companies hire thousands of young talent on apna.co
CRISIL MI&A: Sector Vector - Reading the topical trends - Power demand in India moderates as monsoon coverage improves
CRISIL Ratings: Resolution nods under IBC up by a record 42% in fiscal 2024
Elara Securities India: FY25 India Union Budget - Bolstering the basics: Fiscal prudence stays
Kotak Institutional Equities: Assessing the impact of budget proposal for real estate
Bond Market Reaction from Union Budget 2024-25 by Puneet Pal, Head - Fixed Income , PGIM India Mutual Fund
SBI Capital Market Report on Union Budget 2024-25: BROAD-BASING DEVELOPMENT AND A NOD TO STABILITY
Kotak Institutional Equities: Strategy: FY2025 union budget: Prudent and balanced
Recovery in domestic cotton yarn demand to be gradual in FY2025: ICRA
CRISIL Ratings: Jute makers to see margins drop for the second straight fiscal
Kotak Institutional Equities: Metals & Mining: Steel prices under downward pressure
Securitisation volumes estimated at about Rs. 45,000 crore for Q1 FY2025: ICRA
CRISIL Ratings: Small and medium REITs to broaden realty investor base
Axis Securities' Monthly Auto Volume Update - July 2024
Kotak Institutional Equities: Diversified financials: AMCs & RTAs - In beta mode
Kotak Institutional Equities: Automobiles & Components: Weak retail trends across segments
More financial power to women: A study by Axis Mutual Fund reveals a remarkable increase in women investor base with ~72% taking investment decisions independently
Kotak Institutional Equities: Crop & Chemical Dashboard: China output growth is a worry
Kotak Institutional Equities: Strategy: Promoters selling, retail (through MFs) buying
Kotak Institutional Equities: Strategy: Foreign fund-flow tracker, June 2024